Nitric oxide and glomerulonephritis

Seminars in Nephrology

Volumn 24, Issue 4, 2004, Pages 324-332

  Trachtman, Howard ^a  

^a SCHNEIDER CHILDREN'S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; THYMOCYTE ANTIBODY;

AUTOIMMUNE DISEASE; CELL INFILTRATION; DISEASE SEVERITY; ENDOTHELIUM CELL; EVALUATION; GLOMERULONEPHRITIS; GLOMERULOPATHY; GLOMERULUS BASEMENT MEMBRANE; GLOMERULUS CAPILLARY; GLOMERULUS FILTRATION; HEYMANN NEPHRITIS; HUMAN; IMMUNE INJURY; IMMUNOCOMPETENT CELL; INFUSION; KIDNEY CELL; KIDNEY INJURY; MOLECULE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEINURIA; REVIEW;

EID: 3142634794     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2004.04.004     Document Type: Article

References (71)

1. Ketteler M., Distler A. The role of nitric oxide in experimental glomerulonephritis. Kidney Blood Press Res. 19:1996;177-181
2. Cattell V. Nitric oxide and glomerulonephritis. Kidney Int. 61:2002;816-821
3. Cattell V. Nitric oxide and glomerulonephritis. Semin Nephrol. 19:1999;277-287
4. Anders H.J., Vielhauer V., Schlondorff D. Chemokines and chemokine receptors are involved in the resolution or progression of renal disease. Kidney Int. 63:2003;401-415
5. Pfeilschifter J., Beck K.F., Eberhardt W., et al. Changing gears in the course of nephritis by shifting superoxide to nitric oxide-dominated chemistry. Kidney Int. 61:2002;809-815
6. Li B., Yao J., Morioka T., et al. Nitric oxide increases albumin permeability of isolated rat glomeruli via a phosphorylation-dependent mechanism. J Am Soc Nephrol. 12:2001;2616-2624
7. Pfeilschifter J. Nitric oxide triggers the expression of proinflammatory and protective gene products in mesangial cells and the inflamed glomerulus. Nephrol Dial Transplant. 17:2002;347-348
8. Lee S.K., Kim C.S., Yang W.S., et al. Exogenous nitric oxide inhibits tumor necrosis factor-alpha or interleukin-1-beta-induced monocyte chemoattractant protein-1 expression in human mesangial cells. Role of IκB-alpha and cyclic GMP. Nephron. 92:2002;780-787
9. Kashiwagi M., Masutani K., Shinozaki M., et al. MCP-1 and RANTES are expressed in renal cortex of rats chronically treated with nitric oxide inhibitor Involvement in macrophage and monocyte recruitment. Nephron. 92:2002;165-173
10. Kashem A., Endoh M., Yano N., et al. Expression of inducible-NOS in human glomerulonephritis The possible source is infiltrating monocytes/macrophages. Kidney Int. 50:1996;392-399
11. Waddington S., Cook T.H., Reaveley D., et al. L-arginine depletion inhibits glomerular nitric oxide synthesis and exacerbates nephrotoxic nephritis. Kidney Int. 49:1996;1090-1096
12. Waddington S.N., Mosley K., Cattell V. Induced nitric oxide (NO) synthesis in heterologous nephrotoxic nephritis Effects of selective inhibition in neutrophil-dependent glomerulonephritis. Clin Exp Immunol. 113:1998;258-264
13. Gomez-Guerrero C., Lopez-Franco O., Suzuki Y., et al. Nitric oxide production in renal cells by immune complexes Role of kinases and nuclear factor-κB. Kidney Int. 62:2002;2022-2034
14. Narita I., Border W.A., Ketteler M., et al. Nitric oxide mediates immunologic injury to kidney mesangium in experimental glomerulonephritis. Lab Invest. 72:1995;17-24
15. Ishizuka I., Cunard R., Poucell-Hatton S., et al. Agmatine inhibits cell proliferation and improves renal function in anti-Thy1 glomerulonephritis. J Am Soc Nephrol. 11:2000;2256-2264
16. Peters H., Borders W.A., Noble N.A. L-arginine supplementation increases mesangial cell injury and subsequent tissue fibrosis in experimental glomerulonephritis. Kidney Int. 55:1999;2264-2273
17. Goto S., Yamamoto T., Feng L., et al. Expression and localization of inducible nitric oxide synthase in anti-Thy-1 glomerulonephritis. Am J Pathol. 147:1995;1133-1141
18. Walpen S., Beck K.F., Schaefer L., et al. Nitric oxide induces MIP-2 transcription in a rat renal mesangial cells and in a rat model of glomerulonephritis. FASEB J. 15:2001;571-573
19. Ketteler M., Westenfeld R., Gawlik A., et al. Nitric oxide synthase isoform expression in acute versus chronic anti-Thy1 nephritis. Kidney Int. 61:2002;826-833
20. Mosley K., Waddington S.N., Ebrahim H., et al. Inducible nitric oxide synthase induction in Thy1 glomerulonephritis is complement and reactive oxygen species dependent. Exp Nephrol. 7:1999;26-34
21. Lopez-Franco O., Suzuki Y., Sanjuan G., et al. Nuclear factor-kappa B inhibitors as potential novel anti-inflammatory agents for the treatment of immune nephritis. Am J Pathol. 161:2002;1497-1505
22. Lianos E.A., Liu J. changes in inducible nitric oxide synthase expression in experimental glomerulonephritis. Proc Soc Exp Biol Med. 215:1997;405-411
23. Bremmer V., Tojo A., Kimura K., et al. Role of nitric oxide in rat nephrotoxic nephritis Comparison between inducible and constitutive nitric oxide synthase. J Am Soc Nephrol. 8:1997;1712-1721
24. Cook H.T., Jansen A., Lewis S., et al. Arginine metabolism in experimental glomerulonephritis Interaction between nitric oxide synthase and arginase. Am J Physiol. 267:1994;F646-F653
25. Waddington S.N., Tam F.W.K., Cook T.H., et al. Arginase activity is modulated by IL-4 and HOArg in nephritic glomeruli and mesangial cells. Am J Physiol. 274:1998;F473-F480
26. Waddington S.N., Mosley K., Cook T.H., et al. Arginase AI is upregulated in acute immune complex-induced inflammation. Biochem Biophys Res Commun. 247:1998;84-87
27. Waddington S.N. Arginase in glomerulonephritis. Kidney Int. 61:2002;876-881
28. Datta P.K., Reddy R.S., Lianos E.A. Effects of all-trans retinoic acid (atRA) on inducible nitric oxide synthase (iNOS) activity and transforming growth factor beta-1 production in experimental anti-GBM antibody-mediated glomerulonephritis. Inflammation. 25:2001;351-359
29. Ogawa D., Shikata K., Matsuda M., et al. Protective effect of novel and selective inhibitor of inducible nitric oxide synthase on experimental crescentic glomerulonephritis in WKY rats. Nephrol Dial Transplant. 17:2002;2117-2121
30. Waddington S.N., Mosley K., Cattell V. Induced nitric oxide (NO) synthesis in heterologous nephrotoxic nephritis Effects of selective inhibition in neutrophil-dependent glomerulonephritis. Clin Exp Immunol. 118:1999;309-314
31. Lianos E.A., Guglielmi K., Sharma M. Regulatory interactions between inducible nitric oxide synthase and eicosanoids in glomerular immune injury. Kidney Int. 53:1998;645-653
32. Datta P.K., Koukouritaki S.B., Hopp K.A., et al. Heme-oxygenase-1 induction attenuates inducible nitric oxide synthase expression and proteinuria in glomerulonephritis. J Am Soc Nephrol. 10:1999;2540-2550
33. Datta P.K., Gross E.J., Lianos E.A. Interactions between inducible nitric oxide synthase and heme oxygenase-1 in glomerulonephritis. Kidney Int. 61:2002;847-850
34. Nihei T., Arai Km Miura Y., Yagasaki K. Arginine as an exacerbating factor for glomerulonephritis in rats fed a methionine-threonine-supplemented low casein diet. Biosci Biotechnol Biochem. 65:2001;1155-1162
35. Cook H.T., Sullivan R. Glomerular nitrite synthesis in in situ immune complex glomerulonephritis in the rat. Am J Pathol. 139:1991;1047-1052
36. Weinberg J.B. Nitric oxide as an inflammatory mediatorin autoimmune MRL-lpr/lpr mice. Environ Health Perspect. 106:1998;1131-1137
37. Reilly C.M., Oates J.C., Cook J.A., et al. Inhibition of mesangial nitric oxide production in MRL/lpr mice by prostaglandin J2 and proliferator activation receptor-gamma agonists. J Immunol. 164:2000;1498-1504
38. Keng T., Privalle C.T., Gilkeson G.S., et al. Peroxynitrite formation and decreased catalase activity in autoimmune MRL-lpr/lpr mice. Mol Med. 6:2000;779-792
39. Reilly C.M., Farrelly L.W., Viti D., et al. Modulation of renal disease in MRL/lpr mice by pharmacologic inhibition of nitric oxide synthase. Kidney Int. 61:2002;839-846
40. Lui S.L., Tsang R., Wong D., et al. Effect of mycophenolate mofetil on severity of nephritis and nitric oxide production in lupus-prone MRL/lpr mice. Lupus. 11:2002;. 4511-418
41. Yu C.C., Yang C.W., Wu M.S., et al. Mycophenolate mofetil reduces renal cortical inducible nitric oxide synthase mRNA expression and diminishes glomerulosclerosis in MRL/lpr mice. J Lab Clin Med. 138:2001;69-77
42. Yang C.W., Yu C.C., Ko Y.C., et al. Aminoguanidine reduces glomerular inducible nitric oxide synthase (iNOS) and transforming growth factor-beta 1 (TGF-β1) mRNA expression in NZB/W F1 mice. Clin Exp Immunol. 113:1998;258-264
43. Peters H., Border W.A., Ruckert M., et al. L-arginine supplementation accelerates renal fibrosis and shortens life span in experimental lupus nephritis. Kidney Int. 63:2003;1382-1392
44. Van Goor H., Albrecht E.W., Heeringa P., et al. Nitric oxide inhibition enhances platelet aggregation in experimental anti-Thy-12 nephritis. Nitric Oxide. 5:2001;525-533
45. Westenfeld R., Gawlik A., de Heer E., et al. Selective inhibition of inducible nitric oxide synthase enhances intraglomerular coagulation in chronic anti-Thy1 nephritis. Kidney Int. 61:2002;834-838
46. Ferrario R., Takahishi K., Fogo A., et al. Consequence of acute nitric oxide synthesis inhibition in experimental glomerulonephritis. J Am Soc Nephrol. 4:1994;1847-1854
47. Heeringa P., van Goor H., Moshage H., et al. Expression of iNOS, eNOS, and peroxynitrite-modified proteins in experimental anti-myeloperoxidase associated crescentic glomerulonephritis. Kidney Int. 53:1998;382-393
48. Heeringa H., Steenbergen E., van Goor H. A protective role for endothelial nitric oxide synthase in glomerulonephritis. Kidney Int. 61:2002;822-825
49. Wagner L., Riggleman A., Erdely A., et al. Reduced nitric oxide synthase activity in rats with chronic renal disease due to glomerulonephritis. Kidney Int. 62:2002;532-536
50. Heeringa P., van Goor H., Itoh-Lindstrom Y., et al. Lack of endothelial nitric oxide synthase aggravates murine accelerated murine anti-glomerular basement membrane glomerulonephritis. Am J Pathol. 156:2000;879-888
51. Cattell V., Cook H.T., Ebraihim H., et al. Anti-GBM glomerulonephritis in mice lacking nitric oxide synthase type 2. Kidney Int. 53:1998;932-936
52. Uhlenius N., Tikkanen T., Miettinen A., et al. Renoprotective effect of captopril in hypertension induced by nitric oxide synthase inhibition in experimental nephritis. Nephron. 81:1999;221-229
53. Uhlenius N., Tikkanen T., Tikkanen T., et al. Chronic inhibition of nitric oxide synthase in Heymann nephritis. Nephron. 74:1996;144-149
54. Walker L.M., Shah S.V., Mayeux P.R. Lack of a role for inducible nitric oxide synthase in an experimental model of nephritic syndrome. Biochem Pharmacol. 60:2000;137-1453
55. Furusu A., Miyazaki M., Abe K., et al. Expression of endothelial and inducible nitric oxide synthase in human glomerulonephritis. Kidney Int. 53:1998;1760-1768
56. Romagnani P., Lazzeri E., Lasagni L., et al. IP-10 and Mig production by glomerular cells in human proliferative glomerulonephritis and regulation by nitric oxide. J Am Soc Nephrol. 13:2002;53-64
57. Kakoki M., Matsumoto A., Nagata D., et al. Analysis of nitric oxide in exhaled air of patients with chronic glomerulonephritis. Clin Nephrol. 52:1999;83-90
58. Duan S.B., Liu F.Y., Luo J.A., et al. Assessment of urinary endothelin-1 and nitric oxide levels and their relationship with clinical and pathologic types in primary glomerulonephritis. Yonsei Med J. 40:1999;425-429
59. Ho C.Y., Wong C.K., Li E.K., et al. Elevated plasma concentrations of nitric oxide, soluble thrombomodulin, and soluble vascular cell adhesion molecule-1 in patients with systemic lupus erythematosus. J Rheumatol. 42:2003;117-122
60. Wong C.K., Ho C.Y., Li E.K., et al. Elevated production of interleukin-18 is associated with renal disease in patients with systemic lupus erythematosus. Clin Exp Immunol. 130:2002;345-351
61. Belmont H.M., Levartovsky D., Goel A., et al. Increased nitric oxide production accompanied by the up-regulation of inducible nitric oxide synthase in vascular endothelium from patients with systemic lupus erythematosus. Arthritis Rheum. 40:1997;1810-1816
62. Wang J.S., Tseng H.H., Shih D.F., et al. Expression of inducible nitric oxide synthase and apoptosis in human lupus nephritis. Nephron. 77:1997;404-411
63. Gilkeson G., Cannon C., Oates J., et al. Correlation of serum measures of nitric oxide production with lupus disease activity. J Rheumatol. 26:1998;318-324
64. Oates J.C., Christensen E.F., Reilly C.M., et al. Prospective measure of serum 3-nitrotyrosine levels in systemic lupus erythematosus Correlation with disease activity. Proc Assoc Am Physicians. 111:1999;611-621
65. Gonzalez-Crespo M.R., Navarro J.A., Arenas J., et al. Prospective study of serum and urinary nitrite levels in patients with systemic lupus erythematosus. Br J Rheumatol. 37:1998;972-977
66. Roccatello D., Mosso R., Ferro M., et al. Urinary endothelin in glomerulonephritis patients with normal renal function. Clin Nephrol. 41:1994;323-330
67. Roccatello D., Mengozzi G., Ferro M., et al. Isosorbide 5-mononitrate administration increases nitric oxide blood levels and reduces proteinuria in IgA glomerulonephritis patients with abnormal urinary endothelin/cyclic GMP ratio. Clin Nephrol. 44:1995;163-169
68. Amore A., Cirina P., Conti G., et al. Glycosylation of circulating IgA in patients with IgA nephropathy modulates proliferation and apoptosis of mesangial cells. J Am Soc Nephrol. 12:2001;1862-1871
69. Kovacs T., Barta J., Kocsis B., et al. Nitric oxide in IgA nephropathy patients with or without hypertension. Exp Nephrol. 3:1995;369-372
70. Trachtman H., Gauthier B.G., Frank R., et al. Increased urinary nitrite excretion in children with minimal change nephrotic syndrome. J Pediatr. 128:1996;173-176
71. Soylemezoglu O., Ozkaya O., Erbas D., et al. Nitric oxide in Henoch Shoenlein purpura. Scand J Rheumatol. 31:2002;271-274